SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-22-033723
Filing Date
2022-06-21
Accepted
2022-06-21 06:14:07
Documents
12
Period of Report
2022-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea161815-8ka1_immucell.htm   iXBRL 8-K/A 51936
  Complete submission text file 0001213900-22-033723.txt   226152

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE iccc-20220615.xsd EX-101.SCH 2959
3 XBRL LABEL FILE iccc-20220615_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE iccc-20220615_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT ea161815-8ka1_immucell_htm.xml XML 3627
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12934 | Film No.: 221025907
SIC: 2835 In Vitro & In Vivo Diagnostic Substances